Abstract:Background: In recent years, using hydroxyapatite nanoparticles (HANPs) for tumor therapy attracted increasing attention because HANPs were found to selectively suppress the growth of tumor cells but exhibit ignorable toxicity to normal cells. Purpose: This study aimed to investigate the capacities of HANPs with different morphologies and particle sizes against two kinds of osteosarcoma (OS) cells, human OS 143B cells and rat OS UMR106 cells. Methods: Six kinds of HANPs with different morphologies and particle sizes were prepared by wet chemical method. Then, the antitumor effect of these nanoparticles was characterized by means of in vitro cell experiments and in vivo tumor-bearing mice model. The underlying antitumor mechanism involving mitochondrial apoptosis was also investigated by analysis of intracellular calcium, expression of apoptosis-related genes, reactive oxygen species (ROS), and the endocytosis efficiency of the particles in tumor cells. Results: Both in vitro cell experiments and in vivo mice model evaluation revealed the anti-OS performance of HANPs depended on the concentration, morphology, and particle size of the nanoparticles, as well as the OS cell lines. Among the six HANPs, rod-like HANPs (R-HANPs) showed the best inhibitory activity on 143B cells, while needle-like HANPs (N-HANPs) inhibited the growth of UMR106 cells most efficiently. We further demonstrated that HANPs induced mitochondrial apoptosis by selectively raising intracellular Ca2+ and the gene expression levels of mitochondrial apoptosis-related molecules, and depolarizing mitochondrial membrane potential in tumor cells but not in MC3T3-E1, a mouse pre-osteoblast line. Additionally, the anti-OS activity of HANPs also linked with the endocytosis efficiency of the particles in the tumor cells, and their ability to drive oxidative damage and immunogenic cell death (ICD). Conclusion: The current study provides an effective strategy for OS therapy where the effectiveness was associated with the particle morphology and cell line.

Biological Response of Osteosarcoma Cells to Size-Controlled Nanostructured Hydroxyapatite

A Selective Reduction of Osteosarcoma by Mitochondrial Apoptosis Using Hydroxyapatite Nanoparticles

Controllable Synthesis of Different Size Hydroxyapatite Nanoparticles and Their Biological Effects on Osteoblast-Like Cells

Selective Effects of Hydroxyapatite Nanoparticles on Osteosarcoma Cells and Osteoblasts.

Hydroxyapatite-Bovine Serum Albumin-Paclitaxel Nanoparticles for Locoregional Treatment of Osteosarcoma

Inhibition of Proliferation of Osteosarcoma by Nano Calcium Phosphates: Potential Hard Tissue Repair after Tumor Extraction

Size effect of hydroxyapatite nanoparticles on proliferation and apoptosis of osteoblast-like cells

A multiple drug loaded, functionalized pH-sensitive nanocarrier as therapeutic and epigenetic modulator for osteosarcoma

Zoledronic Acid-Loaded Hybrid Hyaluronic Acid/Polyethylene Glycol/Nano-Hydroxyapatite Nanoparticle: Novel Fabrication and Safety Verification

Role of hydroxyapatite nanoparticle size in bone cell proliferation

Orchestrated Tumor Apoptosis (cu2+) and Bone Tissue Calcification (ca2+) by Hierarchical Copper/Calcium-ensembled Bioactive Silica for Osteosarcoma Therapy

Synthesis, Characterization, and Biological Evaluation of Nanostructured Hydroxyapatite with Different Dimensions

Effects of Four Types of Hydroxyapatite Nanoparticles with Different Nanocrystal Morphologies and Sizes on Apoptosis in Rat Osteoblasts.

Tumor Microenvironment-Responsive Hyaluronate-Calcium Carbonate Hybrid Nanoparticle Enables Effective Chemotherapy for Primary and Advanced Osteosarcomas

Recent Advances in Nanoplatforms for the Treatment of Osteosarcoma

Recent advances on nanostructured biomaterials in osteosarcoma treatment

Cell responses to two kinds of nanohydroxyapatite with different sizes and crystallinities.

Experimental Study of the Inhibitory Effect of Hydroxyapatite Nanoparticles on Osteosarcoma MG63 in Vitro

Bioinspired Tumor‐Targeting and Biomarker‐Activatable Cell‐Material Interfacing System Enhances Osteosarcoma Treatment via Biomineralization

A bone-targeting permeable nanomicelle acting as an icebreaker for enhancing chemotherapy of osteosarcoma

Antitumor Effect by Hydroxyapatite Nanospheres: Activation of Mitochondria-Dependent Apoptosis and Negative Regulation of Phosphatidylinositol-3-Kinase/Protein Kinase B Pathway.